Skip to main content
TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
165.00
-0.98 (-0.59%)
At close: Sep 20, 2024, 4:00 PM
164.40
-0.60 (-0.36%)
After-hours: Sep 20, 2024, 7:35 PM EDT

TransMedics Group Revenue

TransMedics Group had revenue of $114.31M in the quarter ending June 30, 2024, with 117.87% growth. This brings the company's revenue in the last twelve months to $358.76M, up 137.47% year-over-year. In the year 2023, TransMedics Group had annual revenue of $241.62M with 158.53% growth.

Revenue (ttm)
$358.76M
Revenue Growth
+137.47%
P/S Ratio
15.08
Revenue / Employee
$614,313
Employees
584
Market Cap
5.50B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023241.62M148.16M158.53%
Dec 31, 202293.46M63.20M208.83%
Dec 31, 202130.26M4.62M18.03%
Dec 31, 202025.64M2.04M8.62%
Dec 28, 201923.60M10.59M81.33%
Dec 29, 2018 Pro Pro Pro
Dec 30, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 30, 2006 Pro Pro Pro
Dec 31, 2005 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Organon & Co. 6.35B
Option Care Health 4.59B
RadNet 1.71B
Stevanato Group 1.17B
Sotera Health Company 1.10B
Ultragenyx Pharmaceutical 481.30M
BridgeBio Pharma 219.12M
Krystal Biotech 166.23M
Revenue Rankings

TMDX News

More News